Skip to main content
OpenTrials

Clinical trial condition

Lymphohistiocytosis, Hemophagocytic

Explore clinical trials studying Lymphohistiocytosis, Hemophagocytic. Study availability and eligibility vary by location and protocol.

65 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Lymphohistiocytosis, Hemophagocytic trial results

Completed

HLH Patients - a Retrospective Study

NCT05531721

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations
  • AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita Turin, Italy
View Trial Details
Completed

Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis

NCT01818492

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Alfred I. duPont Hospital for Children - Nemours Center for Cancer and Blood Disorders - Division of Pediatric Hematology Oncology Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Completed

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

NCT01998633

Conditions
Blood Protein Disorders, Chronic Active Epstein-Barr Virus Infection, Chronic Disease, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

NCT02069899

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, Histiocytosis, +3 more
Locations
  • Spectrum Health Helen Devos Children's Hospital Grand Rapids, Michigan, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital - Division of Immunobiology Cincinnati, Ohio, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View all 16 locations
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

NCT03311854

Conditions
Adult Onset Still Disease, Arthritis, Arthritis, Juvenile, +17 more
Locations
  • Cincinnati Children'S Hospital Cincinnati, Ohio, United States
  • Hôpital Necker-Enfants Malades, Unité d'Immunologie-hématologie et Rhumatologie pédiatriques Paris, France
  • IRCCS Ospedale Pediatrico, Bambino Gesù Rome, Italy
  • Hospital Sant Joan de Deu Barcelona, Spain
View Trial Details
Completed

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

NCT00919503

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +51 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Completed

Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis

NCT01104025

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, Histiocytosis, +3 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California, San Francisco Department of Pediatrics San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 15 locations
View Trial Details

Related conditions